The score is driven primarily by strong financial quality—especially the zero-debt balance sheet and solid profitability—partly offset by weaker technicals with the stock trading below major moving averages. Reasonable valuation and a ~4% dividend yield provide support despite mixed recent operating momentum and uneven cash-flow conversion.
Positive Factors
Balance Sheet Strength
A zero-debt balance sheet with growing equity materially reduces financial risk and interest burden, preserving flexibility to fund capex, brand investment, or dividends from internal resources. Over the next 2–6 months this low leverage supports resilience to shocks and strategic optionality.
Sustained Profitability
Consistently healthy net margins and resilient net income indicate enduring pricing power and operational efficiency in a mature FMCG tobacco business. Such margin durability supports ongoing cash generation and ability to sustain shareholder returns even if top-line growth is uneven over the medium term.
Diversified Product Portfolio & Distribution
A multi-brand portfolio and broad Indian distribution reduce concentration risk and allow the company to address varied consumer segments. This structural market footprint supports volume resilience, mix management, and targeted pricing strategies that remain relevant for market share and revenue stability over months.
Negative Factors
Recent Revenue Decline
A reported revenue decline signals weakening top-line momentum or adverse mix shifts, which can erode operating leverage and limit reinvestment capacity. Over a 2–6 month horizon continued top-line softness could pressure margins and constrain strategic initiatives tied to volume recovery.
Margin Compression
Compression from prior margin peaks points to higher input, manufacturing, or tax pressures and/or pricing limits. Persistent margin erosion reduces free cash flow potential and may force trade-offs between pricing, cost cuts, and capex, creating a material headwind to durable profitability.
Uneven Cash-Flow Conversion
Volatile free-cash-flow conversion and working-capital swings undermine predictability of internal funding for dividends, capex and growth. Over several months, inconsistent OCF-to-income conversion increases risk that management must rely on operational adjustments rather than steady organic cash to finance priorities.
VST Industries Limited (VSTIND) vs. iShares MSCI India ETF (INDA)
Market Cap
₹38.00B
Dividend Yield3.93%
Average Volume (3M)14.81K
Price to Earnings (P/E)18.2
Beta (1Y)1.03
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees772
SectorConsumer Defensive
Sector Strength42
IndustryTobacco
Share Statistics
EPS (TTM)3.55
Shares Outstanding169,861,110
10 Day Avg. Volume10,935
30 Day Avg. Volume14,815
Financial Highlights & Ratios
PEG Ratio-4.35
Price to Book (P/B)3.50
Price to Sales (P/S)3.31
P/FCF Ratio30.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
VST Industries Limited Business Overview & Revenue Model
Company DescriptionVST Industries Limited engages in the manufacture, distribution, and trading of cigarettes in India and internationally. It also trades in unmanufactured tobacco. The company was formerly known as Vazir Sultan Tobacco Company Limited and changed its name to VST Industries Limited in April 1983. VST Industries Limited was incorporated in 1930 and is based in Hyderabad, India.
How the Company Makes MoneyVST Industries primarily makes money by selling tobacco products—mainly cigarettes—into the Indian market through wholesale/retail distribution. Its core revenue stream is the invoiced sale of cigarette sticks/packets across different price points and brand variants, with volumes and mix (premium vs. value offerings) influencing revenue realization. A smaller portion of revenue can come from other tobacco-related products (such as smoking tobacco), depending on the company’s reported segment/product mix. Earnings are driven by (1) consumer demand and pricing power by brand/segment, (2) distribution reach and retailer availability, (3) input costs (tobacco leaf and packaging) and manufacturing efficiency, and (4) government excise and other taxes/regulation that materially affect pricing, margins, and volume. Specific partnerships or customer concentration details are null.
Overall fundamentals are strong, led by an excellent balance sheet (zero debt, solid and growing equity, strong ROE). Profitability remains healthy but has softened with FY2025 revenue decline and margin compression versus earlier peaks. Cash generation is positive but uneven, with volatile free-cash-flow conversion despite a FY2025 rebound.
Income Statement
73
Positive
Profitability remains solid with consistently healthy net margins (~21–28%) and strong returns on sales, but the trajectory has softened: revenue declined in FY2025 (after modest growth in prior years) and margins have generally compressed from FY2020–FY2021 highs (gross and EBITDA margins lower in recent periods). Net income is relatively resilient, but top-line momentum and margin pressure are key watch items.
Balance Sheet
90
Very Positive
Balance sheet strength is a standout: the company reports zero debt across the period, with equity steadily growing and strong returns on equity (~22–33%). This low-leverage profile provides meaningful flexibility and reduces financial risk, though ROE has eased versus earlier peaks as profitability and/or asset efficiency moderated.
Cash Flow
56
Neutral
Cash generation is positive but less consistent than earnings. Operating cash flow is positive each year, and free cash flow rebounded strongly in FY2025, but free cash flow was negative in FY2023 and conversion is uneven (free cash flow to net income ranges from weak to strong across years). Operating cash flow also covers a relatively modest portion of net income in the latest year, pointing to working-capital and timing volatility.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026